Regis Healthcare Limited (ASX:REG)
6.57
0.00 (0.00%)
At close: Feb 10, 2026
Regis Healthcare Market Cap
Regis Healthcare has a market cap or net worth of 1.99 billion as of February 10, 2026. Its market cap has increased by 3.36% in one year.
Market Cap
1.99B
Enterprise Value
1.80B
Revenue
1.16B
Ranking
n/a
PE Ratio
40.78
Stock Price
6.57
Market Cap Chart
Since October 7, 2014, Regis Healthcare's market cap has increased from 1.21B to 1.99B, an increase of 64.53%. That is a compound annual growth rate of 4.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 1.99B | -5.47% |
| Dec 31, 2025 | 2.10B | 16.26% |
| Dec 31, 2024 | 1.81B | 84.75% |
| Dec 29, 2023 | 978.36M | 72.49% |
| Dec 30, 2022 | 567.21M | 0.83% |
| Dec 31, 2021 | 562.56M | -1.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 86.95B |
| Sigma Healthcare | 35.88B |
| Pro Medicus | 16.84B |
| Cochlear | 16.55B |
| Telix Pharmaceuticals | 3.34B |
| Mesoblast | 3.06B |
| 4DMedical | 1.97B |
| Neuren Pharmaceuticals | 1.69B |